218 related articles for article (PubMed ID: 18576148)
1. Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.
Vella LJ; Hill AF
Methods Mol Biol; 2008; 459():69-82. PubMed ID: 18576148
[TBL] [Abstract][Full Text] [Related]
2. Exosomes: a bubble ride for prions?
Février B; Vilette D; Laude H; Raposo G
Traffic; 2005 Jan; 6(1):10-7. PubMed ID: 15569241
[TBL] [Abstract][Full Text] [Related]
3. Prions and exosomes: from PrPc trafficking to PrPsc propagation.
Porto-Carreiro I; Février B; Paquet S; Vilette D; Raposo G
Blood Cells Mol Dis; 2005; 35(2):143-8. PubMed ID: 16099696
[TBL] [Abstract][Full Text] [Related]
4. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
5. Generation of Infectious Prions and Detection with the Prion-Infected Cell Assay.
Vella LJ; Coleman B; Hill AF
Methods Mol Biol; 2017; 1658():105-118. PubMed ID: 28861786
[TBL] [Abstract][Full Text] [Related]
6. Cell culture models to unravel prion protein function and aberrancies in prion diseases.
Bedecs K
Methods Mol Biol; 2008; 459():1-20. PubMed ID: 18576144
[TBL] [Abstract][Full Text] [Related]
7. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
8. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions.
Kitamoto T; Mohri S; Ironside JW; Miyoshi I; Tanaka T; Kitamoto N; Itohara S; Kasai N; Katsuki M; Higuchi J; Muramoto T; Shin RW
Biochem Biophys Res Commun; 2002 Jun; 294(2):280-6. PubMed ID: 12051707
[TBL] [Abstract][Full Text] [Related]
9. An improved method for cell-to-cell transmission of infectious prion.
Tanaka M; Hara H; Nishina H; Hanada K; Hagiwara K; Maehama T
Biochem Biophys Res Commun; 2010 Jul; 397(3):505-8. PubMed ID: 20515650
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
11. Antiprion properties of prion protein-derived cell-penetrating peptides.
Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
[TBL] [Abstract][Full Text] [Related]
12. Cells release prions in association with exosomes.
Fevrier B; Vilette D; Archer F; Loew D; Faigle W; Vidal M; Laude H; Raposo G
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9683-8. PubMed ID: 15210972
[TBL] [Abstract][Full Text] [Related]
13. Cell-free formation of misfolded prion protein with authentic prion infectivity.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15818-23. PubMed ID: 17030802
[TBL] [Abstract][Full Text] [Related]
14. Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.
Arima K; Nishida N; Sakaguchi S; Shigematsu K; Atarashi R; Yamaguchi N; Yoshikawa D; Yoon J; Watanabe K; Kobayashi N; Mouillet-Richard S; Lehmann S; Katamine S
J Virol; 2005 Jun; 79(11):7104-12. PubMed ID: 15890950
[TBL] [Abstract][Full Text] [Related]
15. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid.
Vella LJ; Greenwood DL; Cappai R; Scheerlinck JP; Hill AF
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):385-93. PubMed ID: 18501435
[TBL] [Abstract][Full Text] [Related]
17. Packaging of prions into exosomes is associated with a novel pathway of PrP processing.
Vella LJ; Sharples RA; Lawson VA; Masters CL; Cappai R; Hill AF
J Pathol; 2007 Apr; 211(5):582-590. PubMed ID: 17334982
[TBL] [Abstract][Full Text] [Related]
18. Cellular pathogenesis in prion diseases.
Crozet C; Beranger F; Lehmann S
Vet Res; 2008; 39(4):44. PubMed ID: 18413130
[TBL] [Abstract][Full Text] [Related]
19. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
Masel J; Genoud N; Aguzzi A
J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
[TBL] [Abstract][Full Text] [Related]
20. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
